TCL Archive BSA Eliminates Second Review For P01 Grants; R01Payline To increase to 24th Percentile November 23, 1997
TCL Archive Perot Systems To Provide IT Support For US Oncology Enterprise Applications. December 15, 2000
TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive OSI “Front Line Office” In Probes Of Scientific Misconduct, Kimes Tells NCAB October 13, 1989
TCL Archive In Brief: NCI Claim “Major Finding” In Treatment Of Soft Tissue Sarcoma With Three Modalities; 93% Survival October 9, 1981
